Rchr
J-GLOBAL ID:200901098295821769   Update date: Jan. 30, 2024

Furukawa Tatsuhiko

フルカワ タツヒコ | Furukawa Tatsuhiko
Affiliation and department:
Job title: professor
Research field  (2): Pathobiochemistry ,  Cell biology
Research theme for competitive and other funds  (39):
  • 2021 - 2024 CD147/basiginを標的とした乾癬の新規治療の開発
  • 2021 - 2024 Mechanisms analysis of lung cancer suppression and cell death by an autophagy inducible gene BHLHE41.
  • 2019 - 2022 Approach to regulatory mechanism of copy number variation the gene amplified.
  • 2016 - 2020 Evaluation of moleclar bases for suppression of gene amplification
  • 2015 - 2018 Identify and database creation of gene expression related mercury in liver of the small Indian mongoose using HiCEP analysis
Show all
Papers (176):
  • Tatsuhiko Furukawa, Kentaro Mimami, Toshiyuki Nagata, Masatasu Yamamoto, Masami Sato, Akihide Tanimoto. Approach to Functions of BHLHE41/DEC2 in Non-Small Lung Cancer Development. International journal of molecular sciences. 2023. 24. 14
  • Taiji Hamada, Michiyo Higashi, Seiya Yokoyama, Toshiaki Akahane, Masanori Hisaoka, Hirotsugu Noguchi, Tatsuhiko Furukawa, Akihide Tanimoto. MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer. BMC cancer. 2023. 23. 1. 424-424
  • Shota Takumi, Kairi Hashimoto, Masaru Tomioka, Mina Sato, Weijie He, Yumiko Komatsu, Shunji Aoki, Ryuji Ikeda, Kazuhiro Shiozaki, Tatsuhiko Furukawa, et al. Acteoside from Conandron ramondioides Reduces Microcystin-LR Cytotoxicity by Inhibiting Intracellular Uptake Mediated by OATP1B3. Planta medica. 2023. 89. 6. 616-623
  • Tatsuhiko Furukawa, Sho Tabata, Kentaro Minami, Masatatsu Yamamoto, Kohichi Kawahara, Akihide Tanimoto. Metabolic reprograming of cancer as a therapeutic target. Biochimica et biophysica acta. General subjects. 2022. 1867. 3. 130301-130301
  • Masaya Aoki, Kazuhiro Ueda, Go Kamimura, Yoshiyuki Iwamoto, Mizuki Ikehata, Keisuke Tabata, Yuri Sakagami, Shoichiro Morizono, Takuya Tokunaga, Tadashi Umehara, et al. Clinical significance of ALKBH4 expression in non-small cell lung cancer. Translational cancer research. 2022. 11. 7. 2040-2049
more...
MISC (104):
  • 古川龍彦, 南謙太朗, 山本雅達, 河原康一. FARP1はインテグリンαvβ5に結合し,その発現上昇は進行胃がんの予後に関わる. 日本癌学会学術総会抄録集(Web). 2021. 80th
  • 古川龍彦, 河原康一, 南謙太朗. FARP1 boosts CDC42 activity through Integrin αvβ5 and correlates unfavorable prognoses of the patients carrying advanced gastric cancer. 日本がん分子標的治療学会学術集会プログラム・抄録集. 2021. 25th
  • 古川龍彦, 南健太朗, 河原康一, 新里能成. BHLHE41 suppress lung adeno carsinoma development. 日本がん分子標的治療学会学術集会プログラム・抄録集. 2020. 24th
  • 古川龍彦, 南謙太朗, 山本雅達, 河原康一, 新里能成. BHLHE41 a prognositic factor of lung adenocarcinoma, can induce authophagic cell death to lung cancer cells. 日本癌学会学術総会抄録集(Web). 2020. 79th
  • 古川 龍彦, 田畑 祥, 曽我 朋義. 【代謝が変える細胞と個体の運命】チミジン異化経路を介したがん細胞の低栄養抵抗性と悪性化. 生化学. 2019. 91. 1. 50-56
more...
Books (2):
  • Core protein of receptor for ┣DBDolichos biflorus(/)-┫DB agglutinin isolated from murine teratocarcinoma共著
    Glycoconjugate in Medicine, Professional Postgraduate Service 1988
  • Core protein of receptor for ┣DBDolichos biflorus(/)-┫DB agglutinin isolated from murine teratocarcinoma共著
    Glycoconjugate in Medicine, Professional Postgraduate Service 1988
Education (4):
  • - 1989 Kagoshima University
  • - 1989 Kagoshima University Graduate School, Division of Medicine
  • - 1983 Kagoshima University Faculty of Medicine Department of Medicine
  • - 1983 Kagoshima University Faculty of Medicine
Professional career (1):
  • (BLANK)
Committee career (1):
  • がん分子標的治療研究会 会員
Association Membership(s) (4):
がん分子標的治療研究会 ,  日本分子生物学会 ,  日本生化学会 ,  日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page